Status:
UNKNOWN
Effect Of Azithromycin in Women at Risk of Preterm Labour
Lead Sponsor:
Beni-Suef University
Conditions:
Preterm Labor
Eligibility:
FEMALE
20-40 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to evaluate the benefit of the addition of azithromycin to standard treatments to prolong pregnancy in women having intact membranes and is at risk of or in preterm labour.
Detailed Description
Study Design: Comparative controlled study. Study site : The study will be conducted at the department of Obstetrics and Gynecology at Beni-Suef University Hospital. Study period: The study will ...
Eligibility Criteria
Inclusion
- 24 \< Pregnancy \<37 weeks of gestation.
- Threat or history of preterm labour.
- Preterm labour itself (Non established)
Exclusion
- antibiotics use within 14 days (except for pericerclage prophylaxis, or streptococcus B prophylaxis);
- PPROM; and fetal extraction required \<37 weeks.
- Current or past history of medical diseases (Diabetes Milletus, Hypertension, Systemic Lupus Erythematosus, Cardiac diseases, etc ).
- Adverse perinatal outcome due to abdominal trauma.
- Structural fetal anomalies detected during anomaly scan.
- Allergy to Azithromycin.
Key Trial Info
Start Date :
July 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05971654
Start Date
July 30 2023
End Date
May 30 2024
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt, 62521